These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 15094082)
1. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Brands AM; Kessels RP; de Haan EH; Kappelle LJ; Biessels GJ Eur J Pharmacol; 2004 Apr; 490(1-3):159-68. PubMed ID: 15094082 [TBL] [Abstract][Full Text] [Related]
2. [Diabetic encephalopathy: an underexposed complication of diabetes mellitus]. Brands AM; Henselmans JM; de Haan EH; Biessels GJ Ned Tijdschr Geneeskd; 2003 Jan; 147(1):11-4. PubMed ID: 12564291 [TBL] [Abstract][Full Text] [Related]
3. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Sima AA; Kamiya H; Li ZG Eur J Pharmacol; 2004 Apr; 490(1-3):187-97. PubMed ID: 15094085 [TBL] [Abstract][Full Text] [Related]
4. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. Manschot SM; Biessels GJ; Rutten GE; Kessels RP; Gispen WH; Kappelle LJ; J Neurol Sci; 2008 Jan; 264(1-2):157-62. PubMed ID: 17850822 [TBL] [Abstract][Full Text] [Related]
5. Therapy insight: the impact of type 1 diabetes on brain development and function. Northam EA; Rankins D; Cameron FJ Nat Clin Pract Neurol; 2006 Feb; 2(2):78-86. PubMed ID: 16932529 [TBL] [Abstract][Full Text] [Related]
6. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus. González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804 [TBL] [Abstract][Full Text] [Related]
7. Peripheral insulin and brain structure in early Alzheimer disease. Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409 [TBL] [Abstract][Full Text] [Related]
8. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity. Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of central nervous system complications in diabetes mellitus. Mooradian AD Clin Neurosci; 1997; 4(6):322-6. PubMed ID: 9358975 [TBL] [Abstract][Full Text] [Related]
11. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Brands AM; Kessels RP; Hoogma RP; Henselmans JM; van der Beek Boter JW; Kappelle LJ; de Haan EH; Biessels GJ Diabetes; 2006 Jun; 55(6):1800-6. PubMed ID: 16731845 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis. Watson GS; Craft S J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207 [TBL] [Abstract][Full Text] [Related]
13. Insulin and the insulin receptor in experimental models of learning and memory. Zhao WQ; Chen H; Quon MJ; Alkon DL Eur J Pharmacol; 2004 Apr; 490(1-3):71-81. PubMed ID: 15094074 [TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism. Ott V; Benedict C; Schultes B; Born J; Hallschmid M Diabetes Obes Metab; 2012 Mar; 14(3):214-21. PubMed ID: 21883804 [TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants. van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ; Timely Top Med Cardiovasc Dis; 2007 Feb; 11():E7. PubMed ID: 17380217 [TBL] [Abstract][Full Text] [Related]
16. The Ins2Akita mouse as a model of early retinal complications in diabetes. Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643 [TBL] [Abstract][Full Text] [Related]
17. Protection of pancreatic beta-cells: is it feasible? Bonora E Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375 [TBL] [Abstract][Full Text] [Related]
18. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Wessels AM; Scheltens P; Barkhof F; Heine RJ Eur J Pharmacol; 2008 May; 585(1):88-96. PubMed ID: 18396273 [TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetic neuropathy and C-peptide. Sima AA; Zhang W; Grunberger G Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372 [TBL] [Abstract][Full Text] [Related]
20. Brain insulin signalling in the regulation of energy balance and peripheral metabolism. Diamant M Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]